Offer teenagers a meningitis B vaccine on NHS, advisers tell UK government | Meningitis

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all UK teenagers be offered a meningitis vaccine on the NHS. This policy shift follows fatal outbreaks in Kent and Berkshire, aiming to provide the menB vaccine to 15-year-olds and implement catch-up programs for those who missed infant doses.

JCVI Recommends MenB Booster for 15-Year-Olds

The JCVI is calling for the government to introduce a booster jab for teenagers around age 15 who received the menB vaccine as infants. According to the committee, the first group to receive this booster will be those turning 15 in 2030.

For children who never received the vaccine as babies, the recommendation includes two doses. Specifically, the committee “strongly supports” a two-dose regimen for children born on or before April 30, 2015. This group missed the initial NHS infant rollout and currently lacks baseline protection.

Prof Wei Shen Lim, chair of the JCVI, stated that invasive meningococcal disease is a “rare but very serious illness” with the potential for “devastating impact on lives.” Lim noted that the committee’s decision integrated lived experiences from families of those who died or suffered life-changing complications.

Did you know? Meningitis B (MenB) is the most common bacterial form of the disease. In England, between 300 and 400 cases of meningococcal disease are diagnosed annually.

Fatal Outbreaks Drive Vaccination Shift

The recommendation follows a series of outbreaks that the UK Health Security Agency (UKHSA) described as “unprecedented.” In March, an outbreak linked to a nightclub in Canterbury, Kent, killed two people and required hospital treatment for over a dozen others. Experts characterized this specific spread as the quickest they had ever witnessed.

A separate outbreak in Berkshire in May resulted in the death of a school student. These events spurred advocacy from families, including the parents of 18-year-old Juliette Kenny, who died during the Kent outbreak and campaigned for routine teenage vaccinations.

To address immediate risks, the UK launched a one-off vaccination campaign this summer. This effort targeted roughly one million young people entering university or residential further education this autumn.

Impact on Public Health Strategy

Dr Tom Nutt, chief executive of Meningitis Now, called the JCVI’s recommendation a “significant moment in the fight against meningitis.” Nutt argued that this age group remains at an increased risk for MenB disease and that the move is a landmark step toward preventing further deaths.

The current strategy focuses on closing the “protection gap” for those who missed infant vaccines and bolstering immunity for those whose initial protection has waned by mid-adolescence.

Pro Tip: If you are a parent or student, check your immunization records via the NHS App or your GP to see if you fall into the “missed” cohort born before April 2015.

Meningococcal Disease Facts

Feature Details
Definition Infection of the brain and spinal cord’s protective lining.
Common Strain Meningitis B (MenB).
Annual UK Cases 300 to 400 diagnosed in England.

Frequently Asked Questions

Who is eligible for the new meningitis vaccine?
The JCVI recommends the vaccine for 15-year-olds. This includes boosters for those vaccinated as infants and a two-dose series for those born on or before April 30, 2015, who missed their infant jabs.

When will the booster be available?
The first cohort intended for the booster will be those who turn 15 in 2030.

Why is the vaccine being offered to university students now?
A one-off campaign was launched this summer as a precaution for approximately one million students moving into residential education.

What is the difference between meningitis and MenB?
Meningitis is a general term for inflammation of the brain and spinal cord lining. MenB is a specific, common bacterial form of this disease.

Want to stay updated on UK health alerts? Subscribe to our healthcare newsletter or share your thoughts on the new vaccination rollout in the comments below.

Leave a Comment